The global drug screening market is experiencing rapid growth, reaching a value of USD 7.97 billion in 2024. This growth trajectory shows no signs of slowing down, with projections indicating a robust CAGR of 13.8% from 2025 to 2034. By 2034, the market is expected to soar to USD 25.50 billion. This surge is largely driven by the increasing prevale